Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China

  Agreement expands international presence of Acetadote(R) and Caldolor(R) NASHVILLE, Tenn., Feb. 28, 2012 (CRWENEWSWIRE) – Cumberland Pharmaceuticals Inc. (Nasdaq:CPIX) today announced it has entered into an exclusive agreement with China’s Harbin Gloria Pharmaceuticals Co., Ltd. (SHE:002437.SZ)for the commercialization of Acetadote(R) (acetylcysteine), its injectable drug used to treat acetaminophen overdose, and Caldolor(R) (ibuprofen) Injection, which [...]